4.5 Article

After Patient Death, FDA Places Hold on Pfizer Duchenne Muscular Dystrophy Gene Therapy Trial

Journal

HUMAN GENE THERAPY
Volume 33, Issue 3-4, Pages 111-115

Publisher

MARY ANN LIEBERT, INC
DOI: 10.1089/hum.2022.29198.bfs

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available